Study results suggest that pharmacological inhibition of HDAC6 ameliorates established pulmonary hypertension and will be a potential therapeutic target for pulmonary hypertension in the future.284 In addition, resveratrol treatment can also alleviate vascular remodeling and prevent the development of pulmonary hypertension.285. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.